AstraZeneca grants Teva generic Crohn’s drug license
LONDON (SHARECAST) – AstraZeneca has signed a deal with Teva Pharmaceuticals USA to settle patent litigation regarding Teva’s proposed generic version of Astra’s Entocort EC (budesonide) capsules used to treat Crohn’s disease.

Read more on ShareCast